Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Jitongning Tablets in Axial Spondyloarthritis
NCT06000956Phase 3Recruiting
- Sponsor
- Tasly Pharmaceutical Group Co., Ltd.
- Start
- Sep 2023
- Primary completion
- Dec 2026
- Modality
- HM (Herbal Medicine)
- Countries
- 1
01
Overview
A Phase 3 trial of jitongning in axial spondyloarthritis (axSpA), sponsored by Tasly Pharmaceutical Group Co., Ltd.. Started Sep 2023; status: recruiting.
02
Drugs
jitongning
03
Conditions
axial spondyloarthritis (axSpA)
Beyond the preview
Go deeper on NCT06000956.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06000956.